BIOMAT Database Logo BIOMAT Database Logo

[Effect of drug allergy on lung diffusion capacity in acute pneumonia]. 1979

G A Viaznikova, and I P Zamotaev

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D011653 Pulmonary Diffusing Capacity The amount of a gas taken up, by the pulmonary capillary blood from the alveolar gas, per minute per unit of average pressure of the gradient of the gas across the BLOOD-AIR BARRIER. Capacity, Pulmonary Diffusing,Diffusing Capacity, Pulmonary
D004342 Drug Hypersensitivity Immunologically mediated adverse reactions to medicinal substances used legally or illegally. Allergy, Drug,Hypersensitivity, Drug,Drug Allergy,Allergies, Drug,Drug Allergies,Drug Hypersensitivities,Hypersensitivities, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000208 Acute Disease Disease having a short and relatively severe course. Acute Diseases,Disease, Acute,Diseases, Acute
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

G A Viaznikova, and I P Zamotaev
Reduced lung diffusion capacity after Mycoplasma pneumoniae pneumonia.
August 2000, The Pediatric infectious disease journal,
G A Viaznikova, and I P Zamotaev
[Lung diffusion capacity].
September 1962, Nordisk medicin,
G A Viaznikova, and I P Zamotaev
Effect of vagal cooling on lung functional residual capacity in rats with pneumonia.
January 1983, Bulletin europeen de physiopathologie respiratoire,
G A Viaznikova, and I P Zamotaev
[Study on the diffusion capacity of each lung].
June 1970, El Torax,
G A Viaznikova, and I P Zamotaev
The effect of D-penicillamine on lung function parameters (diffusion capacity) in rheumatoid arthritis.
January 1993, Clinical and experimental rheumatology,
G A Viaznikova, and I P Zamotaev
[Lung diffusion capacity in normal children].
January 1972, La Pediatria,
G A Viaznikova, and I P Zamotaev
[LUNG DIFFUSION CAPACITY. A SURVEY].
October 1964, Nordisk medicin,
G A Viaznikova, and I P Zamotaev
Lung diffusion capacity in early cirrhosis: is lung diffusion capacity a predictor of esophageal varices and ascites?
April 2011, Digestive diseases and sciences,
G A Viaznikova, and I P Zamotaev
Reduced diffusion lung capacity in patients with type 2 diabetes mellitus predicts hospitalization for pneumonia.
April 2011, Diabetes research and clinical practice,
G A Viaznikova, and I P Zamotaev
[Diffusion capacity of the lung in silicosis].
January 1966, Medicina thoracalis,
Copied contents to your clipboard!